Differential functions of tissue factor in the trans-activation of cellular signalling pathways

Atherosclerosis. 2007 Sep;194(1):88-101. doi: 10.1016/j.atherosclerosis.2006.10.010. Epub 2006 Nov 29.

Abstract

In this study we examined the ability of tissue factor (TF) alone, or in conjunction with factor VIIa, factor Xa and TFPI in activating a number of key signalling pathways associated with cellular growth, stress and differentiation responses in human endothelial cells. We used luciferase reporter systems to demonstrate the activation of p42/44 MAPK by the TF-FVIIa complex, mediated via the PAR1 receptor. TF alone was capable of interacting with the cell surface and was sufficient to activate the JNK-SAPK pathway and subsequently AP-1, but the level of activation was enhanced by the activity of FXa on PAR1 and 2. Furthermore, the phosphorylated form of the transmembrane-cytoplasmic domain of TF was directly responsible for activation of these pathways. CREB activation occurred in response to TF-FVIIa in a non-protease dependent manner but was lowered on addition of FXa. Finally, NFkappaB activation occurred in response to FVIIa or FXa, with the latter exhibiting higher levels of activation. In conclusion, we have shown that TF is capable of activating differing signalling pathways, via more than one mechanism. The differential influence of TF is modified depending on the presence of other coagulation factors and ultimately acts as a deciding factor in the determination of cellular fate.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cells, Cultured
  • Cyclic AMP Response Element-Binding Protein / metabolism
  • Drug Synergism
  • Endothelial Cells / cytology
  • Endothelial Cells / metabolism*
  • Endothelium, Vascular / cytology
  • Factor VIIa / metabolism
  • Factor VIIa / pharmacology
  • Factor Xa / metabolism
  • Factor Xa / pharmacology
  • Flow Cytometry
  • Humans
  • JNK Mitogen-Activated Protein Kinases / metabolism
  • Lipoproteins / metabolism
  • Lipoproteins / pharmacology
  • Luciferases / genetics
  • MAP Kinase Signaling System / drug effects
  • MAP Kinase Signaling System / physiology*
  • Mitogen-Activated Protein Kinase 1 / metabolism
  • Mitogen-Activated Protein Kinase 3 / metabolism
  • NF-kappa B / metabolism
  • Thromboplastin / genetics
  • Thromboplastin / metabolism*
  • Thromboplastin / pharmacology
  • Transcription Factor AP-1 / metabolism
  • Transfection
  • Umbilical Veins / cytology

Substances

  • CREB1 protein, human
  • Cyclic AMP Response Element-Binding Protein
  • Lipoproteins
  • NF-kappa B
  • Transcription Factor AP-1
  • lipoprotein-associated coagulation inhibitor
  • Thromboplastin
  • Luciferases
  • JNK Mitogen-Activated Protein Kinases
  • Mitogen-Activated Protein Kinase 1
  • Mitogen-Activated Protein Kinase 3
  • Factor VIIa
  • Factor Xa